rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2008-7-16
|
pubmed:abstractText |
Mammographic density is a risk factor for breast cancer. Mammographic density and breast magnetic resonance imaging (MRI) volume (MRIV) assess the amount of fibroglandular tissue in the breast. Mammographic density and MRIV can be modulated with hormonal interventions, suggesting that these imaging modalities may be useful as surrogate endpoint biomarkers for breast cancer chemoprevention trials. We evaluated the effect of raloxifene on mammographic density and MRIV in premenopausal women at increased risk for breast cancer.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-10919644,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11008908,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11008909,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11136842,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11303594,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12239257,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12376506,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12509398,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12592245,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-14693739,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15084246,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15100340,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15125012,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15798166,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-1635085,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-16775175,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-16954474,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-17119062,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-17170217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-17392385,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-179369,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-8118383,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9016235,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9097051,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9820186,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9865433
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1055-9965
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1696-701
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18583470-Breast Neoplasms,
pubmed-meshheading:18583470-Disease Progression,
pubmed-meshheading:18583470-Female,
pubmed-meshheading:18583470-Follow-Up Studies,
pubmed-meshheading:18583470-Humans,
pubmed-meshheading:18583470-Incidence,
pubmed-meshheading:18583470-Magnetic Resonance Imaging,
pubmed-meshheading:18583470-Mammography,
pubmed-meshheading:18583470-Premenopause,
pubmed-meshheading:18583470-Prognosis,
pubmed-meshheading:18583470-Raloxifene,
pubmed-meshheading:18583470-Risk Factors,
pubmed-meshheading:18583470-Selective Estrogen Receptor Modulators,
pubmed-meshheading:18583470-Time Factors
|
pubmed:year |
2008
|
pubmed:articleTitle |
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.
|
pubmed:affiliation |
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. je95@georgetown.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase II
|